🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadju...
Status
Recruiting
Location
University of California, Irvine
Start Date
2025-08-21
Trial ID
NCT06624475
Treatments Being Tested
The primary objective of this study is to determine the feasibility of four...
Status
Completed
Location
Jessa Hospital Hasselt
Start Date
2020-03-04
Trial ID
NCT04205552
Treatments Being Tested
The purpose of this study is to determine if neoadjuvant (treatment before ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-05-17
Trial ID
NCT06295159
Treatments Being Tested
GIANT is an open-label, multi-center, randomized, perioperative (neoadjuvan...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2025-11-28
Trial ID
NCT06816927
Treatments Being Tested
The goal of this clinical trial is to test neoadjuvant dual immunotherapy i...
Status
Recruiting
Location
Melanoma Institute Australia
Start Date
2024-03-11
Trial ID
NCT06151236
Treatments Being Tested
The NESCIO-trial is a multicenter, randomized, open-label, three-arm phase ...
Status
Active Not Recruiting
Location
Netherlands Cancer Institute
Start Date
2022-04-28
Trial ID
NCT05148546
Treatments Being Tested
This randomized phase II trial studies how well nivolumab with or without i...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-02-02
Trial ID
NCT02519322
Treatments Being Tested
Neoadjuvant therapy is feasible in stage II melanoma, and the dual inhibiti...
Status
Active Not Recruiting
Location
Melanoma Institute Australia
Start Date
2023-08-14
Trial ID
NCT05418972
Treatments Being Tested
The purpose of this study is to understand the characteristics of adults di...
Status
Completed
Location
Cardinal Health
Start Date
2025-05-11
Trial ID
NCT07091695
Treatments Being Tested
This phase II trial tests the addition of BMS-986016 (relatlimab) to the us...
Status
Recruiting
Location
Kaiser Permanente Dublin
Start Date
2024-07-15
Trial ID
NCT06029270